Scan to download
BTC $76,044.42 -2.18%
ETH $2,267.35 -2.09%
BNB $621.46 -0.77%
XRP $1.38 -2.33%
SOL $83.33 -2.17%
TRX $0.3234 -0.54%
DOGE $0.0985 +0.35%
ADA $0.2455 -0.98%
BCH $446.01 -0.92%
LINK $9.18 -1.34%
HYPE $39.86 -5.83%
AAVE $96.03 -0.24%
SUI $0.9170 -1.37%
XLM $0.1618 -3.42%
ZEC $331.45 -6.76%
BTC $76,044.42 -2.18%
ETH $2,267.35 -2.09%
BNB $621.46 -0.77%
XRP $1.38 -2.33%
SOL $83.33 -2.17%
TRX $0.3234 -0.54%
DOGE $0.0985 +0.35%
ADA $0.2455 -0.98%
BCH $446.01 -0.92%
LINK $9.18 -1.34%
HYPE $39.86 -5.83%
AAVE $96.03 -0.24%
SUI $0.9170 -1.37%
XLM $0.1618 -3.42%
ZEC $331.45 -6.76%

The listed company Applied DNA Sciences plans to raise up to $58 million through a private placement to initiate its BNB financial strategy

2025-09-30 11:02:54
Collection

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has received a commitment for a private investment in public equity (PIPE) led by institutional investors, with a maximum amount of up to $58 million, to initiate a BNB-based digital asset financial strategy.

The company has secured a total of $27 million in funding commitments through PIPE, which includes cash, stablecoins, and OBNB trust units. In the future, by exercising warrants, the company also expects to receive up to $31 million in additional investment, bringing the total fundraising amount to a maximum of $58 million.

The PIPE transaction is expected to be completed around October 1, 2025. To support its BNB reserve strategy, the company has signed a five-year Strategic Digital Asset Services Agreement with Cypress LLC, which will provide full asset management services.

app_icon
ChainCatcher Building the Web3 world with innovations.